DUBLIN, Calif., Feb. 23 /PRNewswire-FirstCall/ -- SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that it will release its 2008 fourth quarter and fiscal year-end financial results on Monday, March 2, 2009. SuperGen's management team will provide details of the Company's financial results, and provide financial guidance for fiscal year 2009.
A press release will be issued following the close of the market on March 2nd. The Company will host a webcasted conference call to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast will be accessible via the Investor Relations section of the Company's Web site at www.supergen.com. A webcast replay of the live conference call will be available shortly following the event. Alternatively, you may access a replay of the conference call by dialing 1-888-286-8010 (domestic) and 1-617-801-6888 (international); replay passcode number is 21719262. The webcast replay and conference call replay will be available for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts:
SuperGen, Inc.
Timothy L. Enns
S.V.P., Corporate Communications & Business Development
(925) 560-0100
tenns@supergen.com
SuperGen, Inc.
Susanna Chau
Manager, Investor Relations
(925) 560-2845
schau@supergen.com
SOURCE SuperGen, Inc.
For further information: Timothy L. Enns, S.V.P., Corporate Communications & Business Development, +1-925-560-0100, tenns@supergen.com, or Susanna Chau, Manager, Investor Relations, +1-925-560-2845, schau@supergen.com, both of SuperGen, Inc.
© PR Newswire
